News and Events
Stay informed about RECOVER’s Long COVID research by reading the latest news and participating in upcoming events.
Featured News Item
RECOVER-TLC to host next webinar March 26, 2026
NIH and FNIH leaders will share insights and answer questions about the progress being made on the first wave of RECOVER-TLC clinical trials.
Announcement
34 Results
34 Results
RECOVER Research Update: March 2026
Recent RECOVER publications include findings about possible causes of and treatments for Long COVID.
Feature
Researcher leads studies using electronic health data to understand Long COVID in children
Dr. Suchitra Rao’s expertise helps RECOVER’s electronic health record (EHR) and observational studies make important discoveries about Long COVID in children.
Feature
A year of discovery: Looking back at 2025 and ahead to 2026
In 2025, RECOVER’s progress included closing the first phase of its adult observational study and publishing its first clinical trial results. This year, the initiative continues its studies and sharing research findings.
Feature
RECOVER Research Update: December 2025
Researchers across the initiative continue to refine methods to accurately identify Long COVID, learn more about potential treatments, and understand how the condition impacts different groups of people.
Research Update
Electronic health records are an important tool to address Long COVID questions
Electronic health records (EHRs) give researchers the ability to look at large groups of people and understand how Long COVID behaves over a long period of time.
Feature
RECOVER Research Update: September 2025
Recent RECOVER research has revealed important links between Long COVID and a range of other physical, mental, and emotional health conditions.
Research Update
Electronic health record study examines how COVID-19 severity impacts risk of autoimmune diseases
Researchers found that severe COVID-19 can cause a strong immune response, which can cause the body’s immune system to attack itself and lead to new autoimmune diseases.
Feature
RECOVER’s mid-year milestones: A look at 2025 progress
This year, RECOVER researchers continue to publish results from research studies that deepen our understanding of Long COVID. RECOVER studies continue, with 2 clinical trials expected to reach enrollment goals this summer.
Feature